Researchers are excited about the medication , a novel dual compound showing remarkable outcomes in initial trials for size reduction . It acts by targeting both systems: GLP-1 and GIP, that , when https://nicoleqeiz228536.blogpostie.com/61997546/a-new-prospect-for-size-reduction